Morgan Stanley Call 130 iShares Nasdaq Biotechnology ETF 21.03.2025
/ DE000MG251M3
Morgan Stanley Call 130 iShares N.../ DE000MG251M3 /
| 11/10/2024 20:39:38 |
Chg.+0.13 |
Bid22:00:39 |
Ask22:00:39 |
Underlying |
Strike price |
Expiration date |
Option type |
| 1.86EUR |
+7.51% |
-
Bid Size: - |
-
Ask Size: - |
- |
130.00 - |
21/03/2025 |
Call |
Master data
| WKN: |
MG251M |
| Issuer: |
Morgan Stanley |
| Currency: |
EUR |
| Underlying: |
- |
| Type: |
Warrant |
| Option type: |
Call |
| Strike price: |
130.00 - |
| Maturity: |
21/03/2025 |
| Issue date: |
11/04/2024 |
| Last trading day: |
21/03/2025 |
| Ratio: |
10:1 |
| Exercise type: |
American |
| Quanto: |
No |
| Gearing: |
7.01 |
| Leverage: |
Yes |
Calculated values
| Fair value: |
0.83 |
| Intrinsic value: |
0.31 |
| Implied volatility: |
0.48 |
| Historic volatility: |
0.16 |
| Parity: |
0.31 |
| Time value: |
1.59 |
| Break-even: |
149.00 |
| Moneyness: |
1.02 |
| Premium: |
0.12 |
| Premium p.a.: |
0.29 |
| Spread abs.: |
0.01 |
| Spread %: |
0.53% |
| Delta: |
0.61 |
| Theta: |
-0.06 |
| Omega: |
4.27 |
| Rho: |
0.27 |
Quote data
| Open: |
1.64 |
| High: |
1.86 |
| Low: |
1.64 |
| Previous Close: |
1.73 |
| Turnover: |
0.00 |
| Market phase: |
- |
All quotes in EUR
Performance
| 1 Week |
|
|
+9.41% |
| 1 Month |
|
|
-11.00% |
| 3 Months |
|
|
-8.82% |
| YTD |
|
|
- |
| 1 Year |
|
|
- |
| 3 Years |
|
|
- |
| 5 Years |
|
|
- |
| 10 Years |
|
|
- |
| 1W High / 1W Low: |
1.86 |
1.70 |
| 1M High / 1M Low: |
2.23 |
1.70 |
| 6M High / 6M Low: |
2.44 |
0.87 |
| High (YTD): |
- |
- |
| Low (YTD): |
- |
- |
| 52W High: |
- |
- |
| 52W Low: |
- |
- |
| Avg. price 1W: |
|
1.75 |
| Avg. volume 1W: |
|
0.00 |
| Avg. price 1M: |
|
1.88 |
| Avg. volume 1M: |
|
0.00 |
| Avg. price 6M: |
|
1.71 |
| Avg. volume 6M: |
|
0.00 |
| Avg. price 1Y: |
|
- |
| Avg. volume 1Y: |
|
- |
| Volatility 1M: |
|
77.05% |
| Volatility 6M: |
|
103.44% |
| Volatility 1Y: |
|
- |
| Volatility 3Y: |
|
- |
